DOUG JANZEN - Net Worth and Insider Trading
DOUG JANZEN Net Worth
The estimated net worth of DOUG JANZEN is at least $226,977 dollars as of 2024-11-12. DOUG JANZEN is the Director, Senior Officer of Aequus Pharmaceuticals Inc and owns about 12,268,800 shares of Aequus Pharmaceuticals Inc (TSXV:AQS) stock worth over $184,032. DOUG JANZEN is also the Director of Perimeter Medical Imaging AI Inc and owns about 95,433 shares of Perimeter Medical Imaging AI Inc (TSXV:PINK) stock worth over $42,945. Details can be seen in DOUG JANZEN's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that DOUG JANZEN has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of DOUG JANZEN
DOUG JANZEN Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, DOUG JANZEN owns 2 companies in total, including Aequus Pharmaceuticals Inc (TSXV:AQS) , and Perimeter Medical Imaging AI Inc (TSXV:PINK) .
Click here to see the complete history of DOUG JANZEN’s form 4 insider trades.
Insider Ownership Summary of DOUG JANZEN
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:AQS | Aequus Pharmaceuticals Inc | 2022-11-30 | Director & Senior Officer |
| TSXV:PINK | Perimeter Medical Imaging AI Inc | 2021-03-05 | Director |
DOUG JANZEN Latest Holdings Summary
DOUG JANZEN currently owns a total of 2 stocks. Among these stocks, DOUG JANZEN owns 12,268,800 shares of Aequus Pharmaceuticals Inc (TSXV:AQS) as of November 30, 2022, with a value of $184,032 and a weighting of 81.08%. DOUG JANZEN also owns 95,433 shares of Perimeter Medical Imaging AI Inc (TSXV:PINK) as of March 5, 2021, with a value of $42,945 and a weighting of 18.92%.
Latest Holdings of DOUG JANZEN
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:AQS | Aequus Pharmaceuticals Inc | 2022-11-30 | 12,268,800 | 0.02 | 184,032 |
| TSXV:PINK | Perimeter Medical Imaging AI Inc | 2021-03-05 | 95,433 | 0.45 | 42,945 |
Holding Weightings of DOUG JANZEN
DOUG JANZEN Form 4 Trading Tracker
According to the SEC Form 4 filings, DOUG JANZEN has made a total of 18 transactions in Aequus Pharmaceuticals Inc (TSXV:AQS) over the past 5 years, including 18 buys and 0 sells. The most-recent trade in Aequus Pharmaceuticals Inc is the acquisition of 115,000 shares on November 30, 2022, which cost DOUG JANZEN around $3,450.
According to the SEC Form 4 filings, DOUG JANZEN has made a total of 4 transactions in Perimeter Medical Imaging AI Inc (TSXV:PINK) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Perimeter Medical Imaging AI Inc is the acquisition of 2,100 shares on March 5, 2021, which cost DOUG JANZEN around $8,883.
Insider Trading History of DOUG JANZEN
- 1
DOUG JANZEN Trading Performance
GuruFocus tracks the stock performance after each of DOUG JANZEN's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by DOUG JANZEN is 25.87%. GuruFocus also compares DOUG JANZEN's trading performance to market benchmark return within the same time period. The performance of stocks bought by DOUG JANZEN within 3 months outperforms 13 times out of 22 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how DOUG JANZEN's insider trading performs compared to the benchmark.
Performance of DOUG JANZEN
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.91 | | | | | |
| Relative Return to S&P 500(%) | 4.35 | | | | | |
DOUG JANZEN Ownership Network
Ownership Network List of DOUG JANZEN
Ownership Network Relation of DOUG JANZEN
DOUG JANZEN Owned Company Details
What does Aequus Pharmaceuticals Inc do?
Who are the key executives at Aequus Pharmaceuticals Inc?
DOUG JANZEN is the Director & Senior Officer of Aequus Pharmaceuticals Inc.
Aequus Pharmaceuticals Inc (TSXV:AQS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aequus Pharmaceuticals Inc (TSXV:AQS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aequus Pharmaceuticals Inc (TSXV:AQS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aequus Pharmaceuticals Inc (TSXV:AQS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aequus Pharmaceuticals Inc Insider Transactions
DOUG JANZEN Mailing Address
Above is the net worth, insider trading, and ownership report for DOUG JANZEN. Currently GuruFocus does not have mailing address information for DOUG JANZEN.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
